Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
107 result(s) found, displaying 1 to 25
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 9 September 2020
-
Corporate reportsTargets have been met for the measures under the six KPIs
-
Scheduling submissionsPublic submissions made in response to the interim decision on nicotine scheduling published on 23 September 2020
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the current Poisons Standard in relation to nicotine
-
Corporate reportsProposal to prevent the uptake of nicotine containing e-cigarettes by ever users (adolescents and young adults), to support smoking cessation and to reduce nicotine poisonings of children
-
Scheduling decisions (final)Public notice of the delegate's final decision to amend the Poisons Standard in relation to cannabidiol (private application and delegate initiated) - Joint ACMS-ACCS #25 and #26 (June and November 2020).
-
Scheduling decisions (final)Decisions to be included in the February 2021 Poisons Standard
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
TGA laboratory testing reportsThe TGA has released a report summarising the recent laboratory testing of medicinal cannabis products
-
Corporate reportsInsights into therapeutic goods safety regulatory activity for our recalls program.
-
Corporate reportsInsights into manufacturing quality regulatory activity.
-
Corporate reportsThe TGA has published insights into recalls and GMP regulation for 2019-20.
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 19 November 2020
-
Scheduling decisions (final)Final decisions on proposed amendments to the Poisons Standard - ACMS #31 (June 2020) and delegate only decisions relating to chemicals for agricultural and veterinary uses.
-
Scheduling decisions (final)Delegate only decisions to amend the Poisons Standard in relation to azo dyes (derivatives by diazotisation).
-
Corporate reportsResults of communication developmental research undertaken to inform consumer and health professional communication activities for the opioid regulatory reforms.
-
Scheduling decisions (interim)The closing date for public submissions on the delegate's interim decision on nicotine has been extended to Thursday 12 November 2020.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Corporate reportsRead our clinician information sheet on opioid analgesic tapering: summary.